INBS stock news · Intelligent Bio Solutions
Get alerts for INBS
Follow Intelligent Bio Solutions (INBS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for INBS12 health care stocks are changing a lot before the market opens on Tuesday.
NeutralIntelligent Bio Solutions shares fell 8.5% in Tuesday's premarket session. The article gives no company news to explain the fall, so it does not change the company's outlook.
Intelligent Bio Solutions Inc. shares new rules about how stockholder meetings will work.
NeutralINBS clarified how shareholder votes are counted and shared a business presentation. The filing gives no new business results, so it does not change the company's outlook.
Here are 12 health care stocks that changed in value after the market closed on Monday.
NeutralIntelligent Bio Solutions shares rose in after-hours trading. The report gives no business reason for the move, so it does not change the company's outlook.
12 health care stocks changed a lot in prices after the market closed on Thursday.
NeutralIntelligent Bio Solutions shares rose about 10% to $1.85 after hours, but the article reports no business update or reason for the move. It does not change the company's outlook.
Intelligent Bio Solutions Inc. shares now total 3,316,803 after some were used up.
Bad for INBSINBS filed an 8-K showing 285,000 warrants exercised and 4,333 shares issued, raising shares to 3,316,803 and reducing each current share's ownership.
Intelligent Bio Solutions Inc. told the SEC it sent a request to the FDA for approval of its drug test.
Good for INBSThe company submitted a 510(k) to the FDA for a codeine fingerprinting test; I view this as favorable for Intelligent Bio Solutions.
INTELLIGENT BIO SOLUTIONS INC. discloses operational results and financial status (INBS).
NeutralIntelligent Bio Solutions Inc. has filed a Form 8-K detailing its results of operations and financial condition, which is crucial for investors to assess the company's performance and future prospects. This information is expected to lead to immediate trading activity as investors react to the new data.
Shares of Intelligent Bio Solutions jump 18.41% on Monday following ISO 13485:2016 recertification announcement.
NeutralIntelligent Bio Solutions shares surged 18.41% following the announcement of its recertification to ISO 13485:2016, a key regulatory milestone that aligns with FDA standards and supports its efforts to secure FDA clearance for its drug screening technology. This news is expected to enhance investor confidence and drive further interest in the stock.